PYGL

UniProt ID: P06737
Organism: Homo sapiens
Review Status: INITIALIZED
📝 Provide Detailed Feedback

Gene Description

PYGL is the liver isoform of glycogen phosphorylase, the rate-limiting enzyme of glycogenolysis. It is a pyridoxal-5'-phosphate-dependent homodimeric enzyme that phosphorolytically cleaves the alpha-1,4-glycosidic bonds at the non-reducing ends of glycogen, releasing glucose-1-phosphate, and stops about four residues short of alpha-1,6 branch points (which are then processed by the glycogen debranching enzyme). Activity is controlled allosterically (activated by AMP; inhibited by ATP, ADP and glucose-6-phosphate) and covalently by interconversion between an inactive phosphorylase b and an active phosphorylase a form via phosphorylation of Ser15 by phosphorylase kinase and dephosphorylation by protein phosphatase 1. The enzyme acts in the cytosol, predominantly in the liver, where it liberates glucose from stored glycogen to maintain blood glucose during fasting. Loss-of-function variants cause glycogen storage disease type VI (Hers disease), characterized by hepatomegaly and usually mild fasting hypoglycemia.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005829 cytosol
IBA
GO_REF:0000033
ACCEPT
Summary: Glycogen phosphorylase is a soluble cytosolic enzyme; UniProt records the subcellular location as Cytoplasm, cytosol, and this IBA is concordant with Reactome TAS and UniProt-SubCell IEA assignments.
Reason: Cytosol is the correct and well-supported site of action for this cytosolic glycogenolytic enzyme.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
GO:0005980 glycogen catabolic process
IBA
GO_REF:0000033
ACCEPT
Summary: PYGL catalyzes the rate-limiting step of glycogen breakdown, so glycogen catabolic process is its core biological process. This is the correct level of specificity and is supported across the phylogenetic tree of glycogen phosphorylases.
Reason: Glycogen catabolic process is the precise, core biological process of the enzyme; well supported by IBA, experimental data and UniProt.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes the rate-limiting step in glycogen catabolism and plays a key role in maintaining cellular and organismal glucose homeostasis.
GO:0008184 glycogen phosphorylase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Glycogen phosphorylase activity is the defining molecular function of PYGL. The IBA is concordant with direct experimental measurement of catalytic activity on human liver GP and with the EC 2.4.1.1 assignment.
Reason: This is the core catalytic molecular function of the gene product, supported by phylogeny and by direct assay.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when body glucose is scarce.
GO:0004645 1,4-alpha-oligoglucan phosphorylase activity
IEA
GO_REF:0000120
ACCEPT
Summary: This is the EC 2.4.1.1 / RHEA:41732 catalytic activity term (the parent of glycogen phosphorylase activity), assigned by automated pipelines from InterPro and the RHEA reaction. It correctly describes the phosphorolysis of alpha-1,4 glucan bonds and is experimentally confirmed for the human enzyme.
Reason: Correct EC-mapped catalytic activity term; consistent with the experimentally determined reaction and with the more specific glycogen phosphorylase activity term also annotated.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
EC=2.4.1.1 {ECO:0000269|PubMed:22225877}
GO:0005829 cytosol
IEA
GO_REF:0000044
ACCEPT
Summary: Cytosol assigned automatically from the UniProt subcellular-location vocabulary (SL-0091), consistent with the curated Cytoplasm, cytosol location and with the IBA and Reactome TAS cytosol annotations.
Reason: Correct localization for this cytosolic enzyme.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
GO:0005975 carbohydrate metabolic process
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: Broad InterPro-derived process term. It is correct but much more general than the specific glycogen catabolic process that captures PYGL's actual role.
Reason: Not wrong, but a high-level parent superseded by the specific glycogen catabolic process annotation; retained as a general, non-core term.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when body glucose is scarce.
GO:0005977 glycogen metabolic process
IEA
GO_REF:0000117
KEEP AS NON CORE
Summary: ARBA machine-learning process term. Correct but a general parent of glycogen catabolic process, which is the precise role of the enzyme.
Reason: Correct but general; the specific glycogen catabolic process term is the core BP. Retained as a broad, non-core annotation.
Supporting Evidence:
PMID:22225877
GP activity plays an important role in glucose homeostasis and glycogen metabolism.
GO:0008184 glycogen phosphorylase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Automated assignment of the core catalytic molecular function from InterPro/ARBA and mouse ortholog, redundant with and confirmed by the IBA and experimental (IDA/IMP/EXP) annotations to the same term.
Reason: Correctly captures the defining catalytic activity of PYGL.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when body glucose is scarce.
GO:0030170 pyridoxal phosphate binding
IEA
GO_REF:0000002
ACCEPT
Summary: Pyridoxal 5'-phosphate is the essential cofactor of glycogen phosphorylase, covalently bound via a Schiff base to Lys681. This InterPro-based IEA is strongly supported by the curated cofactor annotation and multiple crystal structures.
Reason: PLP binding is a genuine, essential cofactor-binding function of the enzyme (Lys681 pyridoxal-phosphate attachment site).
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
MARK AS OVER ANNOTATED
Summary: Interaction detected in a large-scale binary interactome map; the GOA with/from is PYGB (P11216), the brain glycogen phosphorylase isoform. The bare protein binding term is uninformative about function.
Reason: Bare protein binding gives no functional insight; the underlying PYGB interaction reflects glycogen-phosphorylase isoform association captured more informatively by the identical protein binding (homodimer) annotation. Retained but flagged as over-annotation per curation guidelines.
GO:0005515 protein binding
IPI
PMID:25910212
Widespread macromolecular interaction perturbations in human...
MARK AS OVER ANNOTATED
Summary: Interaction from a systematic interactome-perturbation study; with/from is PYGB (P11216). The bare protein binding term is uninformative.
Reason: Uninformative protein binding term; the PYGB partner reflects glycogen phosphorylase isoform association rather than a distinct function. Retained but flagged as over-annotation.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
MARK AS OVER ANNOTATED
Summary: Interactions from a reference human binary interactome; with/from are PYGB (P11216) and PYGM (P11217), the other glycogen phosphorylase isoforms. The bare protein binding term is uninformative.
Reason: Uninformative protein binding term; the PYGB/PYGM partners reflect glycogen phosphorylase isoform association. Retained but flagged as over-annotation.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: Interaction from a cell-specific interactome-remodeling map; with/from is PYGB (P11216). The bare protein binding term is uninformative.
Reason: Uninformative protein binding term; PYGB partner reflects glycogen phosphorylase isoform association. Retained but flagged as over-annotation.
GO:0005980 glycogen catabolic process
IEA
GO_REF:0000107
ACCEPT
Summary: Automated orthology-based transfer (from mouse Pygl, Q9ET01) of the core glycogen catabolic process, redundant with and confirmed by the IBA annotation to the same term.
Reason: Correctly captures the core biological process of the enzyme; concordant with the IBA and with experimental evidence.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes the rate-limiting step in glycogen catabolism and plays a key role in maintaining cellular and organismal glucose homeostasis.
GO:0004645 1,4-alpha-oligoglucan phosphorylase activity
EXP
PMID:22225877
Acetylation negatively regulates glycogen phosphorylase by r...
ACCEPT
Summary: Zhang et al. directly assayed the phosphorolytic activity of purified human GP, establishing the EC 2.4.1.1 catalytic activity experimentally. This is the EC-mapped parent of glycogen phosphorylase activity.
Reason: Experimentally supported core catalytic function; the enzyme phosphorolyses alpha-1,4 glucan bonds to yield glucose-1-phosphate.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when body glucose is scarce.
GO:0005536 D-glucose binding
IDA
PMID:10980448
Human liver glycogen phosphorylase inhibitors bind at a new ...
ACCEPT
Summary: Crystallographic study of human liver glycogen phosphorylase; glucose is a physiological allosteric inhibitor that binds the enzyme and stabilizes the inactive conformation. The cached record is abstract-only, so the full ligand-binding detail read by the curator is not directly quotable here.
Reason: D-glucose binding is a genuine, physiologically relevant ligand-binding function (product/end-product feedback inhibitor) demonstrated structurally for the human enzyme; experimental IDA, deferring to the full text read by the curator.
Supporting Evidence:
PMID:10980448
functions allosterically by stabilizing the inactive
GO:0005536 D-glucose binding
IDA
PMID:12204691
Structure-activity analysis of the purine binding site of hu...
ACCEPT
Summary: Structure-activity study of human liver GP allosteric sites by crystallography and SPR. D-glucose binding is a genuine allosteric-ligand function; cached record is abstract-only.
Reason: Experimentally supported ligand-binding function of the human enzyme; duplicate of the other D-glucose binding IDA, deferring to full text read by the curator.
Supporting Evidence:
PMID:12204691
regulated by multiple interacting allosteric sites, each of which is a potential
GO:0042802 identical protein binding
IPI
PMID:10980448
Human liver glycogen phosphorylase inhibitors bind at a new ...
ACCEPT
Summary: PYGL is enzymatically active as a homodimer, as established by the crystal structures of human liver GP (with/from P06737, self-interaction). This is the functionally relevant, informative self-association.
Reason: The homodimer is the biologically active unit of glycogen phosphorylase; identical protein binding correctly and informatively captures the self-association (unlike bare protein binding).
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBUNIT: Homodimer; enzymatically active
GO:0005576 extracellular region
TAS
Reactome:R-HSA-6798748
MARK AS OVER ANNOTATED
Summary: Assigned via a Reactome neutrophil-degranulation/secretory-granule exocytosis module. PYGL is a cytosolic glycogenolytic enzyme; its presence in the extracellular region reflects secretome/degranulation cataloguing rather than a site of function.
Reason: PYGL functions in the cytosol; extracellular localization is a bystander catalog assignment from a degranulation pathway, not a functional location.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
GO:0005576 extracellular region
TAS
Reactome:R-HSA-6800434
MARK AS OVER ANNOTATED
Summary: Same as the other extracellular-region assignment, from a Reactome ficolin-rich granule exocytosis module. Not a functional location for this cytosolic enzyme.
Reason: Bystander secretome/degranulation catalog assignment; PYGL acts in the cytosol.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
GO:0034774 secretory granule lumen
TAS
Reactome:R-HSA-6798748
MARK AS OVER ANNOTATED
Summary: From a Reactome secretory-granule exocytosis module. PYGL is cytosolic; granule-lumen localization is a bystander proteomic/degranulation catalog assignment, not a functional site.
Reason: Not a functional location for this cytosolic glycogenolytic enzyme.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
GO:1904813 ficolin-1-rich granule lumen
TAS
Reactome:R-HSA-6800434
MARK AS OVER ANNOTATED
Summary: From a Reactome ficolin-rich granule exocytosis module. As with the other granule/extracellular assignments, this is a bystander catalog location, not the functional site of the cytosolic enzyme.
Reason: Not a functional location for this cytosolic glycogenolytic enzyme.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
GO:0070062 extracellular exosome
HDA
PMID:23533145
In-depth proteomic analyses of exosomes isolated from expres...
MARK AS OVER ANNOTATED
Summary: PYGL was detected among ~900 proteins in a shotgun proteomic survey of exosomes from prostatic secretions in urine. This is a high-throughput proteome-cataloguing localization, not evidence of a functional exosomal role for this cytosolic enzyme.
Reason: Detection in an exosome proteome catalog does not indicate a functional site; PYGL acts in the cytosol.
Supporting Evidence:
PMID:23533145
In pooled EPS-urine exosome samples, ~900 proteins were detected.
GO:0008184 glycogen phosphorylase activity
IDA
PMID:22225877
Acetylation negatively regulates glycogen phosphorylase by r...
ACCEPT
Summary: Zhang et al. directly measured the glycogen phosphorylase catalytic activity of purified human GP (and its regulation by acetylation/PP1), providing direct experimental evidence for this core molecular function.
Reason: Direct experimental demonstration of the core catalytic activity of PYGL.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when body glucose is scarce.
GO:0005829 cytosol
TAS
Reactome:R-HSA-453339
ACCEPT
Summary: Reactome cytosol assignment for the glycogenolysis reaction (glycogen + phosphate to glucose-1-phosphate). This is the correct functional location for PYGL.
Reason: Cytosol is the correct site of the glycogenolytic reaction catalyzed by PYGL; concordant with IBA and UniProt.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
GO:0005829 cytosol
TAS
Reactome:R-HSA-71588
ACCEPT
Summary: Reactome cytosol assignment for the phosphorylase b to a interconversion reaction. Correct functional location.
Reason: Cytosol is the correct site of action; concordant with IBA and UniProt.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
GO:0005829 cytosol
TAS
Reactome:R-HSA-71590
ACCEPT
Summary: Reactome cytosol assignment for glycogen limit-dextrin formation with release of glucose-1-phosphate. Correct functional location.
Reason: Cytosol is the correct site of the glycogenolytic reaction; concordant with IBA and UniProt.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
GO:0002060 purine nucleobase binding
IDA
PMID:12204691
Structure-activity analysis of the purine binding site of hu...
MARK AS OVER ANNOTATED
Summary: Derived from a crystallographic/SPR structure-activity screen of ligands at the purine allosteric inhibitor site of human liver GP, a drug-discovery target site. This binding is real structurally but peripheral to the enzyme's biological function.
Reason: Purine-nucleobase binding reflects a pharmacological/inhibitor-screen site rather than a core physiological binding function; retained but flagged as over-annotation. Not removed, as it is an experimental IDA.
Supporting Evidence:
PMID:12204691
compounds that bind to the purine allosteric inhibitor site.
GO:0005524 ATP binding
IDA
PMID:10949035
Activation of human liver glycogen phosphorylase by alterati...
ACCEPT
Summary: ATP is a physiological allosteric inhibitor of glycogen phosphorylase, binding at the nucleotide (AMP) allosteric site; UniProt records inhibition by ATP among the allosteric controls. The cited crystallographic study of the active/inactive human liver GP is abstract-only in the cache.
Reason: ATP binding at the allosteric nucleotide site is a genuine regulatory binding function of the enzyme (ATP inhibits GP); experimental IDA, deferring to the full text read by the curator.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
being activated by AMP and inhibited by ATP,
GO:0005977 glycogen metabolic process
IMP
PMID:10980448
Human liver glycogen phosphorylase inhibitors bind at a new ...
KEEP AS NON CORE
Summary: Involvement in glycogen metabolism supported by structural/functional study of the human liver enzyme. This is a correct but general parent of the specific glycogen catabolic process, which better captures PYGL's role.
Reason: Correct but general; glycogen catabolic process is the precise core BP. Retained as non-core.
Supporting Evidence:
PMID:10980448
Glycogen phosphorylases catalyze the breakdown of glycogen to glucose-1-phosphate for glycolysis.
GO:0005977 glycogen metabolic process
IMP
PMID:17705025
High frequency of missense mutations in glycogen storage dis...
KEEP AS NON CORE
Summary: GSD6 patients with PYGL mutations show impaired mobilization of glucose from glycogen, implicating PYGL in glycogen metabolism. Correct but a general parent of the specific glycogen catabolic process.
Reason: Correct but general; glycogen catabolic process is the precise core BP. Retained as non-core.
Supporting Evidence:
PMID:17705025
reduced ability to mobilize glucose from glycogen
GO:0008184 glycogen phosphorylase activity
IMP
PMID:10980448
Human liver glycogen phosphorylase inhibitors bind at a new ...
ACCEPT
Summary: Study of the human liver enzyme (active and inactive forms) supports its glycogen phosphorylase catalytic activity. Redundant with the IDA/EXP/IBA annotations to the same core function.
Reason: Correctly captures the core catalytic activity of PYGL.
Supporting Evidence:
PMID:10980448
Glycogen phosphorylases catalyze the breakdown of glycogen to glucose-1-phosphate for glycolysis.
GO:0008184 glycogen phosphorylase activity
IMP
PMID:17705025
High frequency of missense mutations in glycogen storage dis...
ACCEPT
Summary: GSD6-causing missense mutations in PYGL impair enzyme activity, supporting that PYGL enables glycogen phosphorylase activity. Concordant with the core catalytic function.
Reason: Disease mutations that reduce enzyme activity support this core molecular function.
Supporting Evidence:
PMID:17705025
reduced ability to mobilize glucose from glycogen
GO:0008184 glycogen phosphorylase activity
IMP
PMID:9529348
Mutations in the liver glycogen phosphorylase gene (PYGL) un...
ACCEPT
Summary: First identification of PYGL mutations in Hers disease patients, demonstrating that PYGL encodes the liver glycogen phosphorylase whose deficiency abolishes activity. Supports this core molecular function.
Reason: Disease-causing loss-of-function mutations in PYGL support that it enables glycogen phosphorylase activity.
Supporting Evidence:
PMID:9529348
Deficiency of glycogen phosphorylase in the liver gives rise to glycogen-storage disease type VI (Hers disease; MIM 232700).
GO:0016208 AMP binding
IDA
PMID:10949035
Activation of human liver glycogen phosphorylase by alterati...
ACCEPT
Summary: AMP is the classical physiological allosteric activator of glycogen phosphorylase; the crystal structure of human liver GP in complex with AMP was solved (UniProt records AMP-binding residues 43-45, 76, 310), and UniProt notes activation by AMP. A genuine, physiologically important ligand-binding function.
Reason: AMP binding at the allosteric activator site is a core regulatory binding function of the enzyme; supported by structure and by curated binding-site annotation.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
being activated by AMP and inhibited by ATP,
GO:0016208 AMP binding
IDA
PMID:10980448
Human liver glycogen phosphorylase inhibitors bind at a new ...
ACCEPT
Summary: Structural study of human liver GP; AMP is the physiological allosteric activator that binds the nucleotide effector site. Duplicate of the other AMP binding IDA; a core regulatory binding function.
Reason: AMP binding at the allosteric activator site is a genuine, physiologically important binding function of the enzyme.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
being activated by AMP and inhibited by ATP,
GO:0019842 vitamin binding
IDA
PMID:12204691
Structure-activity analysis of the purine binding site of hu...
MARK AS OVER ANNOTATED
Summary: Vitamin binding here refers to the bound pyridoxal 5'-phosphate cofactor (a vitamin B6 derivative) seen in the crystal structures. This is a very general term that is captured more precisely by the pyridoxal phosphate binding annotation.
Reason: Overly general term; the specific and informative pyridoxal phosphate binding term already annotated supersedes it. Retained but flagged.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
GO:0032052 bile acid binding
IDA
PMID:12204691
Structure-activity analysis of the purine binding site of hu...
MARK AS OVER ANNOTATED
Summary: Derived from the same crystallographic/SPR ligand screen of the purine allosteric inhibitor site. Bile-acid binding at a drug-target allosteric pocket is a pharmacological observation, not a physiological function of the enzyme.
Reason: Reflects binding of screened ligands at a drug-discovery allosteric site rather than a biological function; retained but flagged as over-annotation. Not removed, as it is an experimental IDA.
Supporting Evidence:
PMID:12204691
compounds that bind to the purine allosteric inhibitor site.
GO:0042593 glucose homeostasis
IMP
PMID:17705025
High frequency of missense mutations in glycogen storage dis...
KEEP AS NON CORE
Summary: GSD6 caused by PYGL deficiency presents with fasting hypoglycemia, demonstrating that PYGL contributes to organismal glucose homeostasis by mobilizing glucose from hepatic glycogen. This is a physiological, systemic role downstream of the core enzymatic function.
Reason: Genuine organismal/physiological role, but downstream of and secondary to the core glycogen catabolic/enzymatic function; retained as non-core.
Supporting Evidence:
PMID:17705025
reduced ability to mobilize glucose from glycogen

Core Functions

Pyridoxal-5'-phosphate-dependent glycogen phosphorylase that catalyzes the rate-limiting step of glycogenolysis, phosphorolytically cleaving alpha-1,4 glycosidic bonds at the non-reducing ends of glycogen to release glucose-1-phosphate, acting as an active homodimer in the cytosol and allosterically activated by AMP.

Directly Involved In:
Cellular Locations:
Supporting Evidence:
  • PMID:22225877
    Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when body glucose is scarce.
  • file:human/PYGL/PYGL-uniprot.txt
    SUBCELLULAR LOCATION: Cytoplasm, cytosol

Binds pyridoxal 5'-phosphate as an essential covalent cofactor (via a Schiff base to Lys681), which is required for the phosphorolytic catalytic mechanism of glycogen phosphorylase.

Molecular Function:
pyridoxal phosphate binding
Directly Involved In:
Cellular Locations:
Supporting Evidence:
  • file:human/PYGL/PYGL-uniprot.txt
    Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;

References

Gene Ontology annotation through association of InterPro records with GO terms
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods
Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core.
Human liver glycogen phosphorylase inhibitors bind at a new allosteric site.
Structure-activity analysis of the purine binding site of human liver glycogen phosphorylase.
High frequency of missense mutations in glycogen storage disease type VI.
Acetylation negatively regulates glycogen phosphorylase by recruiting protein phosphatase 1.
In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
A proteome-scale map of the human interactome network.
Widespread macromolecular interaction perturbations in human genetic disorders.
A reference map of the human binary protein interactome.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI.
Reactome:R-HSA-453339
poly((1,4)-alpha-glucosyl) glycogenin-2 + n orthophosphate => glycogenin-2 + n D-glucose 1-phosphate [PYGL]
Reactome:R-HSA-6798748
Exocytosis of secretory granule lumen proteins
Reactome:R-HSA-6800434
Exocytosis of ficolin-rich granule lumen proteins
Reactome:R-HSA-71588
glycogen phosphorylase (PYGL) dimer b + 2 ATP => glycogen phosphorylase (PYGL) dimer a + 2 ADP
Reactome:R-HSA-71590
glycogen-glycogenin-2 + n orthophosphate => limit dextrin-glycogenin-2 + n D-glucose 1-phosphate [PYGL]

📚 Additional Documentation

Notes

(PYGL-notes.md)

PYGL (Glycogen phosphorylase, liver form) — review notes

UniProt: P06737 (PYGL_HUMAN), 847 aa, HGNC:9725, chromosome 14. EC 2.4.1.1.

Core biology (from UniProt P06737 + literature)

  • PYGL is the liver isoform of glycogen phosphorylase, the rate-limiting enzyme
    of glycogenolysis. Homodimer; uses a pyridoxal-5'-phosphate (PLP) cofactor
    covalently bound at Lys681 (FT MOD_RES 681 N6-(pyridoxal phosphate)lysine).
  • Reaction (RHEA:41732, EC 2.4.1.1): [(1->4)-alpha-D-glucosyl](n) + phosphate = [(1->4)-alpha-D-glucosyl](n-1) + alpha-D-glucose 1-phosphate. Phosphorolyses
    alpha-1,4 glycosidic bonds at glycogen non-reducing ends, releasing
    glucose-1-phosphate; stops ~4 residues short of alpha-1,6 branch points (then AGL
    debranches). PMID:22225877
  • Allosterically activated by AMP (BINDING 43-45, 76, 310) and inhibited by ATP,
    ADP and glucose-6-phosphate
    (UniProt ACTIVITY REGULATION). Covalent activation:
    phosphorylase kinase (PHK) phosphorylates Ser15, converting inactive b form to
    active a form; PP1 dephosphorylation inactivates it. [PMID:10949035; PMID:22225877]
  • PMID:22225877 (Zhang 2012, full text): acetylation at K470/K796 negatively regulates
    GP by recruiting PP1 via PPP1R3B/G_L; measured catalytic activity of purified human
    GP; establishes EC 2.4.1.1 catalytic activity and PPP1R3B interaction. This is the
    experimental basis for the EXP/IDA glycogen phosphorylase activity and
    1,4-alpha-oligoglucan phosphorylase activity annotations.
  • Subcellular location: Cytoplasm, cytosol (UniProt; ECO:0000305|PubMed:22225877).

Disease

  • Glycogen storage disease type VI (GSD6 / Hers disease; MIM:232700): liver GP
    deficiency → mild-to-moderate fasting hypoglycemia, mild ketosis, growth retardation,
    prominent hepatomegaly; heart and skeletal muscle spared. Predominantly missense
    mutations affecting enzyme activity. [PMID:9529348; PMID:17705025]

Annotation review reasoning

  • Core MF: GO:0008184 glycogen phosphorylase activity (IBA/IDA/IMP/EXP all
    converge). GO:0004645 (1,4-alpha-oligoglucan phosphorylase activity) is the
    parent/EC-mapped term; ACCEPT (EXP-backed by PMID:22225877; IEA is EC/InterPro).
  • Core BP: GO:0005980 glycogen catabolic process (IBA) — the precise process;
    GO:0005977 glycogen metabolic process and GO:0005975 carbohydrate metabolic process
    are correct-but-general parents (KEEP_AS_NON_CORE / accept as broad IEA).
  • Core CC: GO:0005829 cytosol (IBA + IEA + Reactome TAS).
  • Cofactor: GO:0030170 pyridoxal phosphate binding (IEA/InterPro) — ACCEPT; PLP is
    the essential covalent cofactor (Lys681).
  • Ligand-binding IDA terms (D-glucose, AMP, ATP, purine nucleobase, vitamin, bile acid
    binding) come from crystallography of allosteric/inhibitor sites (PMID:10980448,
    PMID:12204691, PMID:10949035; all abstract-only in cache). These are structurally
    real but represent binding at allosteric/drug-discovery sites rather than the core
    catalytic function; AMP binding is the physiological allosteric activator (core-ish),
    while vitamin binding, bile acid binding, purine nucleobase binding are generic/
    drug-screen-derived → MARK_AS_OVER_ANNOTATED. Defer to curator on full text (can't
    REMOVE experimental annotations without reading full text).
  • protein binding (GO:0005515) IPIs (PMID:25416956, 25910212, 32296183, 33961781):
    large-scale interactome maps; with/from = PYGB (P11216), PYGM (P11217) — glycogen
    phosphorylase isoform homo/hetero association. Per policy: bare protein binding →
    MARK_AS_OVER_ANNOTATED (uninformative), not REMOVE.
  • identical protein binding (GO:0042802, IPI, PMID:10980448, with/from P06737):
    homodimer — biologically real (UniProt SUBUNIT: Homodimer). ACCEPT.
  • Extracellular / secretory granule / ficolin granule / exosome localizations
    (GO:0005576, GO:0034774, GO:1904813, GO:0070062): from Reactome neutrophil
    degranulation module (TAS) and a prostate-exosome proteomics screen (HDA,
    PMID:23533145). PYGL is a cytosolic enzyme; these are bystander/secretome-catalog
    localizations, not sites of function → MARK_AS_OVER_ANNOTATED.
  • glucose homeostasis (GO:0042593, IMP, PMID:17705025): GSD6 phenotype (fasting
    hypoglycemia) supports an organismal glucose-homeostasis role; KEEP_AS_NON_CORE
    (systemic/physiological, downstream of the core enzymatic function).

📄 View Raw YAML

id: P06737
gene_symbol: PYGL
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: PYGL is the liver isoform of glycogen phosphorylase, the rate-limiting
  enzyme of glycogenolysis. It is a pyridoxal-5'-phosphate-dependent homodimeric enzyme
  that phosphorolytically cleaves the alpha-1,4-glycosidic bonds at the non-reducing
  ends of glycogen, releasing glucose-1-phosphate, and stops about four residues short
  of alpha-1,6 branch points (which are then processed by the glycogen debranching
  enzyme). Activity is controlled allosterically (activated by AMP; inhibited by ATP,
  ADP and glucose-6-phosphate) and covalently by interconversion between an inactive
  phosphorylase b and an active phosphorylase a form via phosphorylation of Ser15 by
  phosphorylase kinase and dephosphorylation by protein phosphatase 1. The enzyme acts
  in the cytosol, predominantly in the liver, where it liberates glucose from stored
  glycogen to maintain blood glucose during fasting. Loss-of-function variants cause
  glycogen storage disease type VI (Hers disease), characterized by hepatomegaly and
  usually mild fasting hypoglycemia.
alternative_products:
- name: '1'
  id: P06737-1
- name: '2'
  id: P06737-2
  sequence_note: VSP_045339
existing_annotations:
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: Glycogen phosphorylase is a soluble cytosolic enzyme; UniProt records
      the subcellular location as Cytoplasm, cytosol, and this IBA is concordant with
      Reactome TAS and UniProt-SubCell IEA assignments.
    action: ACCEPT
    reason: Cytosol is the correct and well-supported site of action for this
      cytosolic glycogenolytic enzyme.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
    id: GO:0005980
    label: glycogen catabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: PYGL catalyzes the rate-limiting step of glycogen breakdown, so glycogen
      catabolic process is its core biological process. This is the correct level of
      specificity and is supported across the phylogenetic tree of glycogen
      phosphorylases.
    action: ACCEPT
    reason: Glycogen catabolic process is the precise, core biological process of the
      enzyme; well supported by IBA, experimental data and UniProt.
    supported_by:
    - reference_id: PMID:22225877
      supporting_text: Glycogen phosphorylase (GP) catalyzes the rate-limiting step
        in glycogen catabolism and plays a key role in maintaining cellular and
        organismal glucose homeostasis.
- term:
    id: GO:0008184
    label: glycogen phosphorylase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: Glycogen phosphorylase activity is the defining molecular function of
      PYGL. The IBA is concordant with direct experimental measurement of catalytic
      activity on human liver GP and with the EC 2.4.1.1 assignment.
    action: ACCEPT
    reason: This is the core catalytic molecular function of the gene product,
      supported by phylogeny and by direct assay.
    supported_by:
    - reference_id: PMID:22225877
      supporting_text: Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage
        of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when
        body glucose is scarce.
- term:
    id: GO:0004645
    label: 1,4-alpha-oligoglucan phosphorylase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: This is the EC 2.4.1.1 / RHEA:41732 catalytic activity term (the parent
      of glycogen phosphorylase activity), assigned by automated pipelines from
      InterPro and the RHEA reaction. It correctly describes the phosphorolysis of
      alpha-1,4 glucan bonds and is experimentally confirmed for the human enzyme.
    action: ACCEPT
    reason: Correct EC-mapped catalytic activity term; consistent with the
      experimentally determined reaction and with the more specific glycogen
      phosphorylase activity term also annotated.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: EC=2.4.1.1 {ECO:0000269|PubMed:22225877}
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: Cytosol assigned automatically from the UniProt subcellular-location
      vocabulary (SL-0091), consistent with the curated Cytoplasm, cytosol location
      and with the IBA and Reactome TAS cytosol annotations.
    action: ACCEPT
    reason: Correct localization for this cytosolic enzyme.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
    id: GO:0005975
    label: carbohydrate metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: Broad InterPro-derived process term. It is correct but much more general
      than the specific glycogen catabolic process that captures PYGL's actual role.
    action: KEEP_AS_NON_CORE
    reason: Not wrong, but a high-level parent superseded by the specific glycogen
      catabolic process annotation; retained as a general, non-core term.
    supported_by:
    - reference_id: PMID:22225877
      supporting_text: Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage
        of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when
        body glucose is scarce.
- term:
    id: GO:0005977
    label: glycogen metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  qualifier: involved_in
  review:
    summary: ARBA machine-learning process term. Correct but a general parent of
      glycogen catabolic process, which is the precise role of the enzyme.
    action: KEEP_AS_NON_CORE
    reason: Correct but general; the specific glycogen catabolic process term is the
      core BP. Retained as a broad, non-core annotation.
    supported_by:
    - reference_id: PMID:22225877
      supporting_text: GP activity plays an important role in glucose homeostasis and
        glycogen metabolism.
- term:
    id: GO:0008184
    label: glycogen phosphorylase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: Automated assignment of the core catalytic molecular function from
      InterPro/ARBA and mouse ortholog, redundant with and confirmed by the IBA and
      experimental (IDA/IMP/EXP) annotations to the same term.
    action: ACCEPT
    reason: Correctly captures the defining catalytic activity of PYGL.
    supported_by:
    - reference_id: PMID:22225877
      supporting_text: Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage
        of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when
        body glucose is scarce.
- term:
    id: GO:0030170
    label: pyridoxal phosphate binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: Pyridoxal 5'-phosphate is the essential cofactor of glycogen
      phosphorylase, covalently bound via a Schiff base to Lys681. This InterPro-based
      IEA is strongly supported by the curated cofactor annotation and multiple crystal
      structures.
    action: ACCEPT
    reason: PLP binding is a genuine, essential cofactor-binding function of the enzyme
      (Lys681 pyridoxal-phosphate attachment site).
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25416956
  qualifier: enables
  review:
    summary: Interaction detected in a large-scale binary interactome map; the GOA
      with/from is PYGB (P11216), the brain glycogen phosphorylase isoform. The bare
      protein binding term is uninformative about function.
    action: MARK_AS_OVER_ANNOTATED
    reason: Bare protein binding gives no functional insight; the underlying PYGB
      interaction reflects glycogen-phosphorylase isoform association captured more
      informatively by the identical protein binding (homodimer) annotation. Retained
      but flagged as over-annotation per curation guidelines.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25910212
  qualifier: enables
  review:
    summary: Interaction from a systematic interactome-perturbation study; with/from
      is PYGB (P11216). The bare protein binding term is uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: Uninformative protein binding term; the PYGB partner reflects glycogen
      phosphorylase isoform association rather than a distinct function. Retained but
      flagged as over-annotation.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  qualifier: enables
  review:
    summary: Interactions from a reference human binary interactome; with/from are
      PYGB (P11216) and PYGM (P11217), the other glycogen phosphorylase isoforms. The
      bare protein binding term is uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: Uninformative protein binding term; the PYGB/PYGM partners reflect
      glycogen phosphorylase isoform association. Retained but flagged as
      over-annotation.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  qualifier: enables
  review:
    summary: Interaction from a cell-specific interactome-remodeling map; with/from is
      PYGB (P11216). The bare protein binding term is uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: Uninformative protein binding term; PYGB partner reflects glycogen
      phosphorylase isoform association. Retained but flagged as over-annotation.
- term:
    id: GO:0005980
    label: glycogen catabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: Automated orthology-based transfer (from mouse Pygl, Q9ET01) of the core
      glycogen catabolic process, redundant with and confirmed by the IBA annotation
      to the same term.
    action: ACCEPT
    reason: Correctly captures the core biological process of the enzyme; concordant
      with the IBA and with experimental evidence.
    supported_by:
    - reference_id: PMID:22225877
      supporting_text: Glycogen phosphorylase (GP) catalyzes the rate-limiting step
        in glycogen catabolism and plays a key role in maintaining cellular and
        organismal glucose homeostasis.
- term:
    id: GO:0004645
    label: 1,4-alpha-oligoglucan phosphorylase activity
  evidence_type: EXP
  original_reference_id: PMID:22225877
  qualifier: enables
  review:
    summary: Zhang et al. directly assayed the phosphorolytic activity of purified
      human GP, establishing the EC 2.4.1.1 catalytic activity experimentally. This is
      the EC-mapped parent of glycogen phosphorylase activity.
    action: ACCEPT
    reason: Experimentally supported core catalytic function; the enzyme phosphorolyses
      alpha-1,4 glucan bonds to yield glucose-1-phosphate.
    supported_by:
    - reference_id: PMID:22225877
      supporting_text: Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage
        of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when
        body glucose is scarce.
- term:
    id: GO:0005536
    label: D-glucose binding
  evidence_type: IDA
  original_reference_id: PMID:10980448
  qualifier: enables
  review:
    summary: Crystallographic study of human liver glycogen phosphorylase; glucose is
      a physiological allosteric inhibitor that binds the enzyme and stabilizes the
      inactive conformation. The cached record is abstract-only, so the full
      ligand-binding detail read by the curator is not directly quotable here.
    action: ACCEPT
    reason: D-glucose binding is a genuine, physiologically relevant ligand-binding
      function (product/end-product feedback inhibitor) demonstrated structurally for
      the human enzyme; experimental IDA, deferring to the full text read by the
      curator.
    supported_by:
    - reference_id: PMID:10980448
      supporting_text: functions allosterically by stabilizing the inactive
- term:
    id: GO:0005536
    label: D-glucose binding
  evidence_type: IDA
  original_reference_id: PMID:12204691
  qualifier: enables
  review:
    summary: Structure-activity study of human liver GP allosteric sites by
      crystallography and SPR. D-glucose binding is a genuine allosteric-ligand
      function; cached record is abstract-only.
    action: ACCEPT
    reason: Experimentally supported ligand-binding function of the human enzyme;
      duplicate of the other D-glucose binding IDA, deferring to full text read by
      the curator.
    supported_by:
    - reference_id: PMID:12204691
      supporting_text: regulated by multiple interacting allosteric sites, each of
        which is a potential
- term:
    id: GO:0042802
    label: identical protein binding
  evidence_type: IPI
  original_reference_id: PMID:10980448
  qualifier: enables
  review:
    summary: PYGL is enzymatically active as a homodimer, as established by the
      crystal structures of human liver GP (with/from P06737, self-interaction). This
      is the functionally relevant, informative self-association.
    action: ACCEPT
    reason: The homodimer is the biologically active unit of glycogen phosphorylase;
      identical protein binding correctly and informatively captures the
      self-association (unlike bare protein binding).
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: "SUBUNIT: Homodimer; enzymatically active"
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6798748
  qualifier: located_in
  review:
    summary: Assigned via a Reactome neutrophil-degranulation/secretory-granule
      exocytosis module. PYGL is a cytosolic glycogenolytic enzyme; its presence in
      the extracellular region reflects secretome/degranulation cataloguing rather
      than a site of function.
    action: MARK_AS_OVER_ANNOTATED
    reason: PYGL functions in the cytosol; extracellular localization is a bystander
      catalog assignment from a degranulation pathway, not a functional location.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6800434
  qualifier: located_in
  review:
    summary: Same as the other extracellular-region assignment, from a Reactome
      ficolin-rich granule exocytosis module. Not a functional location for this
      cytosolic enzyme.
    action: MARK_AS_OVER_ANNOTATED
    reason: Bystander secretome/degranulation catalog assignment; PYGL acts in the
      cytosol.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
    id: GO:0034774
    label: secretory granule lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6798748
  qualifier: located_in
  review:
    summary: From a Reactome secretory-granule exocytosis module. PYGL is cytosolic;
      granule-lumen localization is a bystander proteomic/degranulation catalog
      assignment, not a functional site.
    action: MARK_AS_OVER_ANNOTATED
    reason: Not a functional location for this cytosolic glycogenolytic enzyme.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
    id: GO:1904813
    label: ficolin-1-rich granule lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6800434
  qualifier: located_in
  review:
    summary: From a Reactome ficolin-rich granule exocytosis module. As with the
      other granule/extracellular assignments, this is a bystander catalog location,
      not the functional site of the cytosolic enzyme.
    action: MARK_AS_OVER_ANNOTATED
    reason: Not a functional location for this cytosolic glycogenolytic enzyme.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:23533145
  qualifier: located_in
  review:
    summary: PYGL was detected among ~900 proteins in a shotgun proteomic survey of
      exosomes from prostatic secretions in urine. This is a high-throughput
      proteome-cataloguing localization, not evidence of a functional exosomal role
      for this cytosolic enzyme.
    action: MARK_AS_OVER_ANNOTATED
    reason: Detection in an exosome proteome catalog does not indicate a functional
      site; PYGL acts in the cytosol.
    supported_by:
    - reference_id: PMID:23533145
      supporting_text: In pooled EPS-urine exosome samples, ~900 proteins were
        detected.
- term:
    id: GO:0008184
    label: glycogen phosphorylase activity
  evidence_type: IDA
  original_reference_id: PMID:22225877
  qualifier: enables
  review:
    summary: Zhang et al. directly measured the glycogen phosphorylase catalytic
      activity of purified human GP (and its regulation by acetylation/PP1),
      providing direct experimental evidence for this core molecular function.
    action: ACCEPT
    reason: Direct experimental demonstration of the core catalytic activity of PYGL.
    supported_by:
    - reference_id: PMID:22225877
      supporting_text: Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage
        of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when
        body glucose is scarce.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-453339
  qualifier: located_in
  review:
    summary: Reactome cytosol assignment for the glycogenolysis reaction (glycogen +
      phosphate to glucose-1-phosphate). This is the correct functional location for
      PYGL.
    action: ACCEPT
    reason: Cytosol is the correct site of the glycogenolytic reaction catalyzed by
      PYGL; concordant with IBA and UniProt.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-71588
  qualifier: located_in
  review:
    summary: Reactome cytosol assignment for the phosphorylase b to a interconversion
      reaction. Correct functional location.
    action: ACCEPT
    reason: Cytosol is the correct site of action; concordant with IBA and UniProt.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-71590
  qualifier: located_in
  review:
    summary: Reactome cytosol assignment for glycogen limit-dextrin formation with
      release of glucose-1-phosphate. Correct functional location.
    action: ACCEPT
    reason: Cytosol is the correct site of the glycogenolytic reaction; concordant
      with IBA and UniProt.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
    id: GO:0002060
    label: purine nucleobase binding
  evidence_type: IDA
  original_reference_id: PMID:12204691
  qualifier: enables
  review:
    summary: Derived from a crystallographic/SPR structure-activity screen of ligands
      at the purine allosteric inhibitor site of human liver GP, a drug-discovery
      target site. This binding is real structurally but peripheral to the enzyme's
      biological function.
    action: MARK_AS_OVER_ANNOTATED
    reason: Purine-nucleobase binding reflects a pharmacological/inhibitor-screen site
      rather than a core physiological binding function; retained but flagged as
      over-annotation. Not removed, as it is an experimental IDA.
    supported_by:
    - reference_id: PMID:12204691
      supporting_text: compounds that bind to the purine allosteric inhibitor site.
- term:
    id: GO:0005524
    label: ATP binding
  evidence_type: IDA
  original_reference_id: PMID:10949035
  qualifier: enables
  review:
    summary: ATP is a physiological allosteric inhibitor of glycogen phosphorylase,
      binding at the nucleotide (AMP) allosteric site; UniProt records inhibition by
      ATP among the allosteric controls. The cited crystallographic study of the
      active/inactive human liver GP is abstract-only in the cache.
    action: ACCEPT
    reason: ATP binding at the allosteric nucleotide site is a genuine regulatory
      binding function of the enzyme (ATP inhibits GP); experimental IDA, deferring to
      the full text read by the curator.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: being activated by AMP and inhibited by ATP,
- term:
    id: GO:0005977
    label: glycogen metabolic process
  evidence_type: IMP
  original_reference_id: PMID:10980448
  qualifier: involved_in
  review:
    summary: Involvement in glycogen metabolism supported by structural/functional
      study of the human liver enzyme. This is a correct but general parent of the
      specific glycogen catabolic process, which better captures PYGL's role.
    action: KEEP_AS_NON_CORE
    reason: Correct but general; glycogen catabolic process is the precise core BP.
      Retained as non-core.
    supported_by:
    - reference_id: PMID:10980448
      supporting_text: Glycogen phosphorylases catalyze the breakdown of glycogen to
        glucose-1-phosphate for glycolysis.
- term:
    id: GO:0005977
    label: glycogen metabolic process
  evidence_type: IMP
  original_reference_id: PMID:17705025
  qualifier: involved_in
  review:
    summary: GSD6 patients with PYGL mutations show impaired mobilization of glucose
      from glycogen, implicating PYGL in glycogen metabolism. Correct but a general
      parent of the specific glycogen catabolic process.
    action: KEEP_AS_NON_CORE
    reason: Correct but general; glycogen catabolic process is the precise core BP.
      Retained as non-core.
    supported_by:
    - reference_id: PMID:17705025
      supporting_text: reduced ability to mobilize glucose from glycogen
- term:
    id: GO:0008184
    label: glycogen phosphorylase activity
  evidence_type: IMP
  original_reference_id: PMID:10980448
  qualifier: enables
  review:
    summary: Study of the human liver enzyme (active and inactive forms) supports its
      glycogen phosphorylase catalytic activity. Redundant with the IDA/EXP/IBA
      annotations to the same core function.
    action: ACCEPT
    reason: Correctly captures the core catalytic activity of PYGL.
    supported_by:
    - reference_id: PMID:10980448
      supporting_text: Glycogen phosphorylases catalyze the breakdown of glycogen to
        glucose-1-phosphate for glycolysis.
- term:
    id: GO:0008184
    label: glycogen phosphorylase activity
  evidence_type: IMP
  original_reference_id: PMID:17705025
  qualifier: enables
  review:
    summary: GSD6-causing missense mutations in PYGL impair enzyme activity,
      supporting that PYGL enables glycogen phosphorylase activity. Concordant with the
      core catalytic function.
    action: ACCEPT
    reason: Disease mutations that reduce enzyme activity support this core molecular
      function.
    supported_by:
    - reference_id: PMID:17705025
      supporting_text: reduced ability to mobilize glucose from glycogen
- term:
    id: GO:0008184
    label: glycogen phosphorylase activity
  evidence_type: IMP
  original_reference_id: PMID:9529348
  qualifier: enables
  review:
    summary: First identification of PYGL mutations in Hers disease patients,
      demonstrating that PYGL encodes the liver glycogen phosphorylase whose deficiency
      abolishes activity. Supports this core molecular function.
    action: ACCEPT
    reason: Disease-causing loss-of-function mutations in PYGL support that it enables
      glycogen phosphorylase activity.
    supported_by:
    - reference_id: PMID:9529348
      supporting_text: Deficiency of glycogen phosphorylase in the liver gives rise to
        glycogen-storage disease type VI (Hers disease; MIM 232700).
- term:
    id: GO:0016208
    label: AMP binding
  evidence_type: IDA
  original_reference_id: PMID:10949035
  qualifier: enables
  review:
    summary: AMP is the classical physiological allosteric activator of glycogen
      phosphorylase; the crystal structure of human liver GP in complex with AMP was
      solved (UniProt records AMP-binding residues 43-45, 76, 310), and UniProt notes
      activation by AMP. A genuine, physiologically important ligand-binding function.
    action: ACCEPT
    reason: AMP binding at the allosteric activator site is a core regulatory binding
      function of the enzyme; supported by structure and by curated binding-site
      annotation.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: being activated by AMP and inhibited by ATP,
- term:
    id: GO:0016208
    label: AMP binding
  evidence_type: IDA
  original_reference_id: PMID:10980448
  qualifier: enables
  review:
    summary: Structural study of human liver GP; AMP is the physiological allosteric
      activator that binds the nucleotide effector site. Duplicate of the other AMP
      binding IDA; a core regulatory binding function.
    action: ACCEPT
    reason: AMP binding at the allosteric activator site is a genuine, physiologically
      important binding function of the enzyme.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: being activated by AMP and inhibited by ATP,
- term:
    id: GO:0019842
    label: vitamin binding
  evidence_type: IDA
  original_reference_id: PMID:12204691
  qualifier: enables
  review:
    summary: Vitamin binding here refers to the bound pyridoxal 5'-phosphate cofactor
      (a vitamin B6 derivative) seen in the crystal structures. This is a very general
      term that is captured more precisely by the pyridoxal phosphate binding
      annotation.
    action: MARK_AS_OVER_ANNOTATED
    reason: Overly general term; the specific and informative pyridoxal phosphate
      binding term already annotated supersedes it. Retained but flagged.
    supported_by:
    - reference_id: file:human/PYGL/PYGL-uniprot.txt
      supporting_text: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
- term:
    id: GO:0032052
    label: bile acid binding
  evidence_type: IDA
  original_reference_id: PMID:12204691
  qualifier: enables
  review:
    summary: Derived from the same crystallographic/SPR ligand screen of the purine
      allosteric inhibitor site. Bile-acid binding at a drug-target allosteric pocket
      is a pharmacological observation, not a physiological function of the enzyme.
    action: MARK_AS_OVER_ANNOTATED
    reason: Reflects binding of screened ligands at a drug-discovery allosteric site
      rather than a biological function; retained but flagged as over-annotation. Not
      removed, as it is an experimental IDA.
    supported_by:
    - reference_id: PMID:12204691
      supporting_text: compounds that bind to the purine allosteric inhibitor site.
- term:
    id: GO:0042593
    label: glucose homeostasis
  evidence_type: IMP
  original_reference_id: PMID:17705025
  qualifier: involved_in
  review:
    summary: GSD6 caused by PYGL deficiency presents with fasting hypoglycemia,
      demonstrating that PYGL contributes to organismal glucose homeostasis by
      mobilizing glucose from hepatic glycogen. This is a physiological, systemic role
      downstream of the core enzymatic function.
    action: KEEP_AS_NON_CORE
    reason: Genuine organismal/physiological role, but downstream of and secondary to
      the core glycogen catabolic/enzymatic function; retained as non-core.
    supported_by:
    - reference_id: PMID:17705025
      supporting_text: reduced ability to mobilize glucose from glycogen
core_functions:
- description: Pyridoxal-5'-phosphate-dependent glycogen phosphorylase that catalyzes
    the rate-limiting step of glycogenolysis, phosphorolytically cleaving alpha-1,4
    glycosidic bonds at the non-reducing ends of glycogen to release glucose-1-phosphate,
    acting as an active homodimer in the cytosol and allosterically activated by AMP.
  molecular_function:
    id: GO:0008184
    label: glycogen phosphorylase activity
  directly_involved_in:
  - id: GO:0005980
    label: glycogen catabolic process
  locations:
  - id: GO:0005829
    label: cytosol
  supported_by:
  - reference_id: PMID:22225877
    supporting_text: Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage
      of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when
      body glucose is scarce.
  - reference_id: file:human/PYGL/PYGL-uniprot.txt
    supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- description: Binds pyridoxal 5'-phosphate as an essential covalent cofactor (via a
    Schiff base to Lys681), which is required for the phosphorolytic catalytic
    mechanism of glycogen phosphorylase.
  molecular_function:
    id: GO:0030170
    label: pyridoxal phosphate binding
  directly_involved_in:
  - id: GO:0005980
    label: glycogen catabolic process
  locations:
  - id: GO:0005829
    label: cytosol
  supported_by:
  - reference_id: file:human/PYGL/PYGL-uniprot.txt
    supporting_text: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:10949035
  title: Activation of human liver glycogen phosphorylase by alteration of the secondary
    structure and packing of the catalytic core.
  findings: []
- id: PMID:10980448
  title: Human liver glycogen phosphorylase inhibitors bind at a new allosteric site.
  findings: []
- id: PMID:12204691
  title: Structure-activity analysis of the purine binding site of human liver glycogen
    phosphorylase.
  findings: []
- id: PMID:17705025
  title: High frequency of missense mutations in glycogen storage disease type VI.
  findings: []
- id: PMID:22225877
  title: Acetylation negatively regulates glycogen phosphorylase by recruiting protein
    phosphatase 1.
  findings: []
- id: PMID:23533145
  title: In-depth proteomic analyses of exosomes isolated from expressed prostatic
    secretions in urine.
  findings: []
- id: PMID:25416956
  title: A proteome-scale map of the human interactome network.
  findings: []
- id: PMID:25910212
  title: Widespread macromolecular interaction perturbations in human genetic disorders.
  findings: []
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings: []
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings: []
- id: PMID:9529348
  title: Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis
    type VI.
  findings: []
- id: Reactome:R-HSA-453339
  title: poly((1,4)-alpha-glucosyl) glycogenin-2 + n orthophosphate => glycogenin-2
    + n D-glucose 1-phosphate [PYGL]
  findings: []
- id: Reactome:R-HSA-6798748
  title: Exocytosis of secretory granule lumen proteins
  findings: []
- id: Reactome:R-HSA-6800434
  title: Exocytosis of ficolin-rich granule lumen proteins
  findings: []
- id: Reactome:R-HSA-71588
  title: glycogen phosphorylase (PYGL) dimer b + 2 ATP => glycogen phosphorylase (PYGL)
    dimer a + 2 ADP
  findings: []
- id: Reactome:R-HSA-71590
  title: glycogen-glycogenin-2 + n orthophosphate => limit dextrin-glycogenin-2 +
    n D-glucose 1-phosphate [PYGL]
  findings: []